The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
quan gan jie ru hua liao jia can yi jiao nang lian he zhi liao zhong wan qi yuan fa xing gan ai xiao guo fen xi
Author(s): 
Pages: 35-36
Year: Issue:  2
Journal: Heilongjiang Medicine And Pharmacy

Keyword:  中晚期原发性肝癌全肝介入化疗参一胶囊;
Abstract: 目的:分析全肝介入化疗加参一胶囊联合治疗中晚期原发性肝癌效果分析.方法:选取我院2014-06~2015-06收治的70例中晚期原发性肝癌患者,随机将其分为观察组(35例)和对照组(35例),对照组给予全肝介入化疗,观察组在全肝介入化疗基础上,加参一胶囊治疗,比较两组患者的治疗效果.结果:经过治疗后,观察组总有效率为64.2%,明显优于对照组的48.9%,两组对比存在显著性差异(P<0.05).观察组生活质量明显高于对照组,观察组治疗后不良反应明显低于对照组,两组对比存在显著性差异(P<0.05).结论:针对中晚期肝癌患者,实施肝全肝介入化疗加参一胶囊联合治疗,可取得良好的临床治疗效果,改善患者生活质量,降低不良反应发生率,值得临床推广应用.
Related Articles
No related articles found